Suppr超能文献

血清学检测为D-/CE+献血者的分子RH血型分型:使用聚合酶链反应-序列特异性引物检测试剂盒对混合样本进行检测。

Molecular RH blood group typing of serologically D-/CE+ donors: the use of a polymerase chain reaction-sequence-specific primer test kit with pooled samples.

作者信息

Londero Donatella, Fiorino Mauro, Miotti Valeria, de Angelis Vincenzo

机构信息

Responsible Immunohematology Laboratory, Department of Transfusion Medicine, AOU "S. Maria della Misericordia", Udine, Italy.

出版信息

Immunohematology. 2011;27(1):25-8.

Abstract

The known presence of RHD blood group alleles in apparently D– individuals who are positive for C or E antigens leads to an appropriate investigation for the RHD gene on the red blood cells (RBCs) of D– blood donors, thus preventing their RBCs from immunizing D– recipients. Ready-to-use polymerase chain reaction–sequence-specific primer (PCR-SSP) typing kits are available and allow single-sample results. The need to perform this testing on a large number of donors affiliated with the Transfusion Department of Udine (Northern Italy) led to the use of molecular genetic RH blood group typing with PCR-SSP test kits and DNA samples mixed in pools. From a population of 35,000 blood donors screened for D antigen by serologic typing, a total of 235 samples, distributed in pools of 5 DNA samples, were investigated. Positive results were reevaluated by opening the pools and retesting single samples. Validation of DNA-pool typing with commercial kits was done. Among 235 genotyped samples, 12 were found to be PCR positive (5.1%), exhibiting DEL genotype and RHD-CE-D hybrid alleles. Our data demonstrate that the use of a PCR-SSP commercial test kit with pooled samples is a helpful and valid method to correctly detect RHD alleles. As a consequence, we reclassified our donors as carriers of potentially immunogenic alleles.

摘要

在C或E抗原呈阳性的看似D抗原阴性个体中,已知存在RHD血型等位基因,这促使对D抗原阴性献血者的红细胞(RBC)进行RHD基因的适当检测,从而防止其红细胞使D抗原阴性受血者产生免疫反应。现成的聚合酶链反应-序列特异性引物(PCR-SSP)分型试剂盒可供使用,并能得出单样本结果。由于需要对乌迪内(意大利北部)输血科的大量献血者进行此项检测,因此采用了分子遗传学RH血型分型方法,使用PCR-SSP检测试剂盒和混合的DNA样本池。在通过血清学分型筛查D抗原的35000名献血者群体中,共调查了235个样本,这些样本以5个DNA样本为一组进行分组。阳性结果通过打开样本池并重新检测单个样本进行重新评估。使用商业试剂盒对DNA样本池分型进行了验证。在235个基因分型样本中,有12个被发现PCR呈阳性(5.1%),表现出DEL基因型和RHD-CE-D杂交等位基因。我们的数据表明,使用带有混合样本的PCR-SSP商业检测试剂盒是正确检测RHD等位基因的一种有用且有效的方法。因此,我们将我们的献血者重新分类为潜在免疫原性等位基因的携带者。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验